Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
BioConferenceLive

Decisive Role in Cell Division Identified for Centrosomal Protein

By BiotechDaily International staff writers
Posted on 30 Aug 2012
Image: The mitotic spindle (microtubules in red, DNA in blue) and the centrosomes (in yellow). (Photo courtesy of Dr. S. Sdelci, IRB Barcelona).
Image: The mitotic spindle (microtubules in red, DNA in blue) and the centrosomes (in yellow). (Photo courtesy of Dr. S. Sdelci, IRB Barcelona).
Image: Depicted are four cells (DNA in blue and a centrosomal protein in red). The cell on the left is in mitosis - observe how the DNA condenses in the chromosomes and the two centrosomes separate and accumulate proteins (maturation) (Photo courtesy of Dr. S. Sdelci, IRB Barcelona).
Image: Depicted are four cells (DNA in blue and a centrosomal protein in red). The cell on the left is in mitosis - observe how the DNA condenses in the chromosomes and the two centrosomes separate and accumulate proteins (maturation) (Photo courtesy of Dr. S. Sdelci, IRB Barcelona).
The answer to an elusive question about signaling in chromosome distribution and separation has been provided by the discovery of a key role for a centrosomal protein kinase. The kinase also has potential importance as a new candidate among cell division factors being targeted in the development of drug treatments for cancer.

The study, headed by principal researchers Joan Roig, PhD, at the Institute for Research in Biomedicine (IRB Barcelona; Barcelona, Spain) and Isabelle Vernos, PhD, at the Center for Genomic Regulation (CRG; Barcelona, Spain) highlights the protein kinase Nek9 as an essential and decisive factor in a pathway involved in ensuring efficient and accurate movement of chromosomes during cell division. γ-tubulin recruitment to and accumulation at the centrosome during the centrosome maturation stage of mitosis is known to depend on the adaptor protein NEDD1/GCP-WD and to be controlled by the kinase Plk1. Surprisingly, and although Plk1 binds and phosphorylates NEDD1 at multiple sites, the mechanism by which this kinase promotes centrosomal recruitment of γ-tubulin has remained elusive. Using Xenopus egg extracts and mammalian cells, the scientists found that Nek9, a kinase required for normal mitotic progression and spindle organization, phosphorylates NEDD1, driving its recruitment and thereby that of γ-tubulin to the centrosome. This role of Nek9 requires its activation by Plk1-dependent phosphorylation.


Errors in chromosome distribution cause many spontaneous miscarriages, some genetic defects such as trisomies, and are related to the development of tumors. Nek9 exerts its action between two molecules, Plk1 and Eg5, of interest as antitumoral agents and for which inhibitors are already in advanced stages of clinical trials. Nek9 could well be added to the list of cell division target candidates. “Through this study we demonstrate that a fourth family of proteins, namely NIMA and specifically Nek9, exert functions in cell division as important as those undertaken by the widely studied CDK (cdk1), Polo (Plk1) and Aurora (Aurora A and B) kinases”, explains Dr. Roig. “Without Nek9 the spindle would not form properly and cell division would be hindered, the cells would die or cause aneuploidies, with unequal distribution of chromosomes, an event that is common in tumors,” explains Dr. Vernos. The pharmaceutical industry is currently testing new drugs that inhibit Plk1, Eg5, and Aurora. “We are doing double-edged work: we describe how proteins involved in the initial stages of cell division are related in time and space, and in parallel we highlight the possible therapeutic tools, whether markers of disease or antimitotic agents, that can stop division and tumor growth”, says Dr. Roig.

The findings were published July 19, 2012, in the journal Current Biology.

Related Links:

Institute for Research in Biomedicine, Barcelona
Center for Genomic Regulation




comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Microcomputed tomography images (top) and histology images (bottom) of the knees of mice fed a very high fat diet containing omega-3 fatty acid supplement (left) or only omega-6 fatty acids (right) after a knee injury. The omega-6 diet showed abnormal bone remodeling and calcified tissue formation in the joint (white arrow). The omega-6 diet also showed significant loss of cartilage (red staining, yellow arrowhead) and increased joint inflammation (Photo courtesy of Duke University).

Dietary Omega-3 Fatty Acids Moderate Severity of Osteoarthritis in a Mouse Model

Researchers working with an osteoarthritis (OA) obese mouse model found that the fat content of the animals' diet contributed more to the development or arrest of OA than did body weight.... Read more

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Therapeutics

view channel

Vaccine Being Developed for Heart Disease Close to Reality

The world’s first vaccine for heart disease is becoming a possibility with researchers demonstrating significant arterial plaque reduction in concept testing in mice. Klaus Ley, MD, from the La Jolla Institute for Allergy and Immunology (LA Jolla, CA, USA), and a vascular immunology specialist, is leading the vaccine... Read more

Business

view channel

A Surge in IPOs Revitalize Investments for the Global Pharma and Biotech

Anti-infective drugs, oncology, and pharmaceutical contract laboratories attract the most investment up to now. The intensified private equity and venture capital (PEVC) deal activity in the global healthcare industry during the recession years, 2008–2010, witnessed a waning post-2010. However, the decline in deals... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.